REMOVED: Short-chain acyl-CoA dehydrogenase gene mutation (319 C>T) presents with clinical heterogeneity and is candidate founder mutation in Ashkenazi Jewish population

Ingrid Tein; Orly Elpeleg; Bruria Ben-Zeev; Stanley H Korman; Alexander Lossos; Dorit Lev; Tally Lerman-Sagie; Gerard Vockley; Gerard T Berry; Anne-Marie Lamhownah; Dieter Matern; Charles R Roe; Niels Gregersen

doi:10.1016/j.ymgme.2006.11.011

REMOVED: Short-chain acyl-CoA dehydrogenase gene mutation (319 C>T) presents with clinical heterogeneity and is candidate founder mutation in Ashkenazi Jewish population

Mol Genet Metab. 2007 Jan 17. doi: 10.1016/j.ymgme.2006.11.011. Online ahead of print.

Authors

Ingrid Tein¹, Orly Elpeleg, Bruria Ben-Zeev, Stanley H Korman, Alexander Lossos, Dorit Lev, Tally Lerman-Sagie, Gerard Vockley, Gerard T Berry, Anne-Marie Lamhownah, Dieter Matern, Charles R Roe, Niels Gregersen

Affiliation

¹ Division of Neurology, Department of Pediatrics, Laboratory Medicine and Pathobiology, The Hospital for Sick Children, University of Toronto, Toronto, Ont., Canada M5G 1X8.

PMID: 17234443
DOI: 10.1016/j.ymgme.2006.11.011

Abstract

This article has been removed, consistent with Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). The Publisher apologizes for any inconvenience this may cause.